Examples of SNPs and aberrant enhancer and super-enhancer activity leading to transcription dysregulation in prostate cancer, for instance due to aberrant expression of the AR or of the c-Myc gene [81,82,83,84,85,86], are detailed below. This evidence concerns the gene AR and prostate cancer.